In July 2025, the Federal Circuit issued a significant ruling in Shockwave Medical, Inc. v. Cardiovascular Systems, Inc. (CSI). The court affirmed the Patent Trial and Appeal Board’s (PTAB) findings that most claims of U.S. Patent No. 8,956,371 were ...
